Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03687658
Collaborator
National Institutes of Health (NIH) (NIH), National Institute on Drug Abuse (NIDA) (NIH)
100
1
2
35.6
2.8

Study Details

Study Description

Brief Summary

This study will evaluate the extent to which we can engage and manipulate putative targets within the self-regulation domain within and outside of laboratory settings in samples of smokers and overweight/obese individuals with binge eating disorder. This is the fourth phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Laddr
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Aim 4
Actual Study Start Date :
Sep 12, 2019
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Binge Eating Group

All participants in the study will be invited to use Laddr, described in the intervention section.

Behavioral: Laddr
Laddr is an integrated, personalized, web-based self-regulation assessment and behavior change system. It integrates tools that have been shown to be effective for a wide array of behavioral phenomena ranging from substance use and abuse, mental health, risk-taking, chronic pain management, medication adherence, diet, exercise, diabetes and other chronic disease management, and smoking. The organizational structure, functionality and content within Laddr's system centrally embrace these fundamental aspects of behavior change; thus, the Laddr platform is not "diagnosis-specific" but rather enables integrated care for any combination of individuals' goals, needs, and preferences.

Experimental: Smoking Group

All participants in the study will be invited to use Laddr, described in the intervention section.

Behavioral: Laddr
Laddr is an integrated, personalized, web-based self-regulation assessment and behavior change system. It integrates tools that have been shown to be effective for a wide array of behavioral phenomena ranging from substance use and abuse, mental health, risk-taking, chronic pain management, medication adherence, diet, exercise, diabetes and other chronic disease management, and smoking. The organizational structure, functionality and content within Laddr's system centrally embrace these fundamental aspects of behavior change; thus, the Laddr platform is not "diagnosis-specific" but rather enables integrated care for any combination of individuals' goals, needs, and preferences.

Outcome Measures

Primary Outcome Measures

  1. Binge eating episodes [binge eating sample only] [28 days]

    [Binge eating sample only] Self-reported binge eating episodes is assessed four times daily (morning, early afternoon, late afternoon/evening, and night) over a 28-day period. A binge eating episode is defined as self-reported overeating and loss of control. Overeating is assessed by the question "Since the last prompt, when you ate most recently, did you overeat?" and is scored as 0 (no) or 1 (yes). Loss of control is assessed by the question "When you ate most recently, did you lose control over your eating?" and is scored as 1 (not at all) to 5 (totally), where a 4 or 5 is considered loss of control.

  2. Smoking episodes [smoking sample only] [Time Frame: 28 days]]

    [Smoking sample only] Self-reported smoking assessed four times daily (morning, early afternoon, late afternoon/evening, and night) over a 28-day period. A smoking episode is defined as self-reported smoking of more than zero cigarettes and is assessed by the question "Since the last prompt, how many cigarettes have you smoked?" Participants are asked to input a number into a number field.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Understand English sufficiently to provide informed consent

  • Right-handed

  • Normal or corrected-to-normal vision and no color blindness

  • Interest in engaging with Laddr to modify self-regulatory behavior

Additional Inclusion Criteria for Smoking sample:
  • Smoke 5 or more tobacco cigarettes/day for past year

  • BMI greater than or equal to 17 and less than 27

Additional Inclusion Criteria for Binge Eating Sample:
  • BMI greater than or equal to 27 and less than 45

  • Weight limit of 350 lbs

  • Non-smoking (defined as no cigarettes in past 12 months-this includes former and never smokers)

Exclusion Criteria:
  • Significant medical illness

  • History of mental disorder due to a medical condition

  • Lifetime history of major psychotic disorders (including schizophrenia and bipolar disorder)

  • Current use of any medication for psychiatric reasons (including stimulants and mood stabilizers)

Additional Exclusion criteria for Binge Eating Sample:
  • Lost weight in recent past (>10 pounds in past 6 months)

  • Currently in a weight-loss program (e.g., Weight Watchers, Jenny Craig)

  • Currently on a special diet for a serious health condition

  • Current engagement in psychotherapy for binge eating disorder

Additional Exclusion Criteria for Smoking Sample:
  • Binge eating behavior

  • Current engagement in psychotherapy for smoking behavior

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford Center for Cognitive and Neurobiological Imaging Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University
  • National Institutes of Health (NIH)
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Russell A Poldrack, PhD, Stanford University
  • Study Director: Patrick G Bissett, PhD, Stanford University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Russell Alan Poldrack, Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT03687658
Other Study ID Numbers:
  • 47143
  • 4UH3DA041713-04
First Posted:
Sep 27, 2018
Last Update Posted:
Sep 22, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2021